Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salicylic Acid Peels Combined With Hydroquinone for Melasma in Hispanic Women
NCT00616239Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2008
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Salvax in melasma, sponsored by UT Southwestern Medical Center. Started Jan 2008; status: completed.
02
Drugs
Salvax
03
Conditions
melasma
Beyond the preview
Go deeper on NCT00616239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616239.